Novo Nordisk A/S holds the cleaner structural position, with profitability as the main driver and stability adding further support. Orion Oyj still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, Orion Oyj carries the stronger setup — intact trend against Novo Nordisk A/S's broken trend. That leaves a split case: the structural lead stays with Novo Nordisk A/S, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.
Profitability drives the lead, while stability keeps the result from looking one-sided. The overall score gap is 15 points in favour of Novo Nordisk A/S.
Both operate in: Drug Manufacturers - General
This comparison is based on industry proximity, not on functional trajectory similarity. NOVO-B.CO and ORNBV.HE share the same industry classification.
For a similarity-based comparison, see how Novo Nordisk A/S and Orion Oyj each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Novo Nordisk A/S and Orion Oyj look relatively close on structure, but the price setup still leans toward Novo Nordisk A/S.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where NOVO-B.CO and ORNBV.HE each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability lead is mainly driven by a 34-point operating margin advantage.
Stability still tilts materially toward Orion Oyj, which stops the result from looking dominant across the whole profile.
The profitability edge is decisive, even though current pricing and stability still lean somewhat toward Orion Oyj.
Break down the NOVO-B.CO vs ORNBV.HE comparison across all dimensions with the full interactive tool.
Explore how NOVO-B.CO and ORNBV.HE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.